[go: up one dir, main page]

AU2002359524A1 - P2x7 receptor antagonists - Google Patents

P2x7 receptor antagonists

Info

Publication number
AU2002359524A1
AU2002359524A1 AU2002359524A AU2002359524A AU2002359524A1 AU 2002359524 A1 AU2002359524 A1 AU 2002359524A1 AU 2002359524 A AU2002359524 A AU 2002359524A AU 2002359524 A AU2002359524 A AU 2002359524A AU 2002359524 A1 AU2002359524 A1 AU 2002359524A1
Authority
AU
Australia
Prior art keywords
receptor antagonists
antagonists
receptor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002359524A
Other versions
AU2002359524A8 (en
Inventor
Kenneth A. Jacobson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
US Department of Health and Human Services
Original Assignee
US Department of Health and Human Services
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by US Department of Health and Human Services filed Critical US Department of Health and Human Services
Publication of AU2002359524A8 publication Critical patent/AU2002359524A8/en
Publication of AU2002359524A1 publication Critical patent/AU2002359524A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/18Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
    • C07D295/182Radicals derived from carboxylic acids
    • C07D295/192Radicals derived from carboxylic acids from aromatic carboxylic acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/36Sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D217/00Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/02Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D217/00Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/22Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
    • C07D217/26Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/645Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having two nitrogen atoms as the only ring hetero atoms
    • C07F9/6509Six-membered rings
    • C07F9/650952Six-membered rings having the nitrogen atoms in the positions 1 and 4

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2002359524A 2001-11-30 2002-11-27 P2x7 receptor antagonists Abandoned AU2002359524A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US33413001P 2001-11-30 2001-11-30
US60/334,130 2001-11-30
PCT/US2002/038126 WO2003047515A2 (en) 2001-11-30 2002-11-27 P2x7 receptor antagonists

Publications (2)

Publication Number Publication Date
AU2002359524A8 AU2002359524A8 (en) 2003-06-17
AU2002359524A1 true AU2002359524A1 (en) 2003-06-17

Family

ID=23305717

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002359524A Abandoned AU2002359524A1 (en) 2001-11-30 2002-11-27 P2x7 receptor antagonists

Country Status (2)

Country Link
AU (1) AU2002359524A1 (en)
WO (1) WO2003047515A2 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2471562A1 (en) * 2001-12-21 2003-07-24 King Pharmaceuticals Research And Development, Inc. Tyrosyl derivatives and their use as p2x7 receptor modulators
US20090124555A1 (en) * 2005-08-29 2009-05-14 Irma Bernatchez-Lemaire Use of histogranin and histogranin-like compounds as inhibitors of p2x7 receptor function and as anti-arthritic agents
NZ587799A (en) 2008-03-25 2012-06-29 Affectis Pharmaceuticals Ag Novel p2x7r antagonists and their use
EP2243772B1 (en) 2009-04-14 2012-01-18 Affectis Pharmaceuticals AG Novel P2X7R antagonists and their use
EA201290876A1 (en) 2010-03-05 2013-03-29 Президент Энд Феллоуз Оф Гарвард Колледж COMPOSITIONS OF INDUCED DENDRITIC CELLS AND THEIR USE
CN102858741A (en) 2010-05-14 2013-01-02 阿费克蒂斯制药股份公司 Novel methods for the preparation of P2X7R antagonists
WO2012110190A1 (en) 2011-02-17 2012-08-23 Affectis Pharmaceuticals Ag Novel p2x7r antagonists and their use
WO2012163792A1 (en) 2011-05-27 2012-12-06 Affectis Pharmaceuticals Ag Novel p2x7r antagonists and their use
WO2012163456A1 (en) 2011-05-27 2012-12-06 Affectis Pharmaceuticals Ag Novel p2x7r antagonists and their use

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5245034A (en) * 1988-12-26 1993-09-14 Kiroyoshi Hidaka Compound having vessel smooth muscle relaxation activity
JPH08119922A (en) * 1994-10-21 1996-05-14 Torii Yakuhin Kk o-pivaloyl-tyrosine derivative

Also Published As

Publication number Publication date
WO2003047515A3 (en) 2004-01-08
AU2002359524A8 (en) 2003-06-17
WO2003047515A2 (en) 2003-06-12

Similar Documents

Publication Publication Date Title
AU2002367424A1 (en) Androgen receptor antagonists
AUPR833401A0 (en) G protein-coupled receptor antagonists
AU2002341834A1 (en) Antagonists
AU2003261392A1 (en) M3muscarinic acetylcholine receptor antagonists
AU2002347022A1 (en) Benzimidazols and indols as glucagon receptor antagonists/inverse agonisten
AU2002365655A1 (en) 5-ht7 receptor antagonists
AU2002351730A1 (en) Glucagon receptor antagonists/inverse agonists
AU2001286409A1 (en) N-methyl-d-aspartate receptor antagonists
AU2001245724A1 (en) Il-8 receptor antagonists
AU2001240021A1 (en) Diazafluorenone il-8 receptor antagonists
AU2002359524A1 (en) P2x7 receptor antagonists
AU2002216079A1 (en) Bombesin receptor antagonists
AU2001243351A1 (en) Il-8 receptor antagonists
AU2002226048A1 (en) Urotensin-ii receptor antagonists
AU2002239506A1 (en) Urotensin-ii receptor antagonists
AU2001241896A1 (en) Il-8 receptor antagonists
AU2002217095A1 (en) Bombesin receptor antagonists
AU2001253172A1 (en) Il-8 receptor antagonists
IL156087A0 (en) Histamine receptor antagonists
AU2001245605A1 (en) Il-8 receptor antagonists
AU2002302774A1 (en) Macrophage receptor agonist or antagonist
AU2002307903A1 (en) G-protein coupled receptor
AU2002257927A1 (en) G-protein coupled receptor
AU2002336181A1 (en) G-protein coupled receptor
AU2002338040A1 (en) Receptor antagonist

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase